Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can learning about pain or using tape ease carpal tunnel symptoms?

NCT ID NCT07539480

Symptom relief Sponsor: Middle East University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests two simple treatments for mild to moderate carpal tunnel syndrome: pain neuroscience education (learning how the brain processes pain) and kinesio taping (applying elastic tape to the wrist). Sixty adults aged 18 to 60 with symptoms for at least 3 months will receive one of these treatments for 6 weeks. Researchers will measure changes in pain, hand function, and grip strength to see which approach works better.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
pain neuroscience education (PNE) and kinesio taping (KT)
What this could lead to
If successful, this could show that simple, non-invasive approaches like education or taping can reduce pain and improve hand function for people with mild to moderate carpal tunnel syndrome.
What could go wrong
This is a small, early-stage trial with only 60 people. Results may not apply to everyone, and neither treatment is expected to cure the condition—only to ease symptoms temporarily.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Jun 2025

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 50 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * aged 18 to 60 years. * Clinically diagnosed unilateral or bilateral carpal tunnel syndrome based on standard diagnostic criteria (e.g., pain, numbness, or tingling in the median nerve distribution), with or without confirmation by nerve conduction studies. * Patients with mild to moderate carpal tunnel syndrome, defined by clinical assessment and electrodiagnostic findings. * Symptoms present for at least 3 months. * Reported wrist or hand pain with functional limitations affecting daily activities. Exclusion Criteria: * Severe CTS characterised by significant thenar muscle atrophy or severe nerve conduction impairment. * Previous Surgery or Injection: * History of carpal tunnel release surgery or corticosteroid injection to the wrist within the past 6 months. * Presence of other conditions affecting the upper limb, such as cervical radiculopathy, peripheral neuropathy, rheumatoid arthritis, tendon rupture, or fractures. * Known neurological disorders (e.g., stroke, multiple sclerosis) or systemic diseases affecting nerve function (e.g., uncontrolled diabetes mellitus). * Skin disease, open wounds, or known allergy to adhesive materials that contraindicate kinesio taping. * Pregnant women, due to possible changes in fluid retention and nerve compression. * Participation in other physical therapy or pain education programmes targeting the upper limbs during the study period. * Conditions that limit comprehension of pain neuroscience education material or ability to provide reliable responses to questionnaires.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Carpal tunnel syndrome (CTS) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

carpal tunnel syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Carpal tunnel syndrome (CTS)

Contacts and locations

Locations

  • Bassam Ahmed Nabil

    October City, Giza Governorate, 6892, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.